Foxconn Industrial Internet (FII) has announced that its subsidiary, Fulian Yukang Medical Technology (Shenzhen), will acquire Guangzhou Tianying Precision Tools in phases at a valuation not exceeding HKD439 million (US$56.51 million).
FII, a member of the Foxconn Group, said that the acquisition will accelerate its strategic positioning in the high-end medical device industry. A signing ceremony for the acquisition was held in Shenzhen, China, on March 7, 2025, attended by senior executives, including FII chairman Brand Cheng, Fulian Yukang chairman Xiang Xuhong, and Guangzhou Tianying president Chen Hanyuan.
Strategic expansion into medical devices
Fulian Yukang is a wholly owned subsidiary that FII established in Shenzhen in 2023. The company operates as a medical device CDMO (contract development and manufacturing organization) enterprise. Leveraging the manufacturing technology, human resources, and financial support of its parent company, Fulian Yukang accelerates business expansion through both organic growth and acquisitions, positioning itself in the professional and consumer medical device sectors to support innovation in the high-end medical device industry, according to FII.
Acquisition brings decades of specialized expertise
Guangzhou Tianying is a medical device manufacturer with over 30 years of experience, according to FII. The company possesses core technologies and process capabilities in metal material processing, with a product portfolio covering more than 5,000 medical devices utilizing over 100 medical-grade materials.
FII said Guangzhou Tianying has obtained verification for finished products from major American orthopedic brands. It has secured orders and entered the supply chain of the world's top five orthopedic brands.
Creating an end-to-end ecosystem
Following the completion of the acquisition, Fulian Yukang will fully integrate Guangzhou Tianying's technologies and resources to create an end-to-end ecosystem from material research and development to finished product delivery. This integration will further strengthen its smart manufacturing capabilities in the high-end medical device sector, enabling the company to provide global clients with higher quality and more responsive solutions, said FII.
Article translated by Rodney Chan and edited by Jerry Chen
